Health
New targets for the development of a drug treatment for obesity and type 2 diabetes – Medical Xpress
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz…
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The study, which has now been published in Cell Metabolism, identifies new targets for the development of a drug treatment for obesity and type 2 diabetes.
Dual-agonists targeting the receptors for Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic…
-
General19 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News22 hours agoSanta drops in for carols
-
Business23 hours agoHow much upside does Macquarie predict for Sonic Healthcare shares?
-
General20 hours agoTwo dead after separate road accidents in regional New South Wales